上海昨日新增本土10+3,其中社会面新增本土无症状感染者1例:上海疫情最新消息(2022.6.20)

2022-06-20 上海市卫健委 上海市卫健委

上海新增本土新冠肺炎确诊病例10例和无症状感染者3例,其中10例确诊病例和2例无症状感染者在隔离管控中发现。

上海市卫健委6月20日通报:2022年6月19日0—24时,上海新增本土新冠肺炎确诊病例10例和无症状感染者3例,其中10例确诊病例和2例无症状感染者在隔离管控中发现。新增境外输入性新冠肺炎确诊病例5例和无症状感染者3例,均在闭环管控中发现。

2022年6月19日0—24时,新增本土新冠肺炎确诊病例10例。新增治愈出院10例。

病例1—病例6,居住于静安区,病例7—病例10,居住于宝山区,为本市闭环隔离管控人员,其间新冠病毒核酸检测结果异常,经疾控中心复核结果为阳性。经市级专家会诊,综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为确诊病例。

2022年6月19日0—24时,新增本土无症状感染者3例。

无症状感染者1,居住于普陀区,无症状感染者2,居住于宝山区,均为本市闭环隔离管控人员,其间新冠病毒核酸检测结果异常,经疾控中心复核结果为阳性,诊断为无症状感染者。

无症状感染者3,居住于宝山区,在风险人群筛查中发现新冠病毒核酸检测结果异常,即被隔离管控。经疾控中心复核结果为阳性,诊断为无症状感染者。(6月19日已通报)

2022年6月19日0—24时,通过口岸联防联控机制,报告5例境外输入性新冠肺炎确诊病例。治愈出院7例,其中来自加拿大2例,来自阿根廷2例,来自纳米比亚1例,来自英国1例,来自美国1例。

病例1为中国籍,在乍得工作,自乍得出发,经法国转机,于2022年6月10日抵达上海浦东国际机场,入关后即被集中隔离观察,其间出现症状。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为确诊病例。

病例2为中国籍,在英国留学,自英国出发,经奥地利转机,于2022年6月11日抵达上海浦东国际机场,入关后即被集中隔离观察,其间出现症状。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为确诊病例。

病例3为中国籍,在美国留学,自美国出发,于2022年6月16日抵达上海浦东国际机场,入关后即被集中隔离观察,其间出现症状。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为确诊病例。

病例4为中国籍,在美国留学,自美国出发,于2022年6月17日抵达上海浦东国际机场,入关后即被集中隔离观察,其间出现症状。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为确诊病例。

病例5为中国籍,在英国留学,自英国出发,经芬兰转机,于2022年6月17日抵达上海浦东国际机场,入关后即被集中隔离观察,其间出现症状。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为确诊病例。

5例境外输入性确诊病例已转至定点医疗机构救治,已追踪同航班密切接触者74人,均已落实集中隔离观察。

2022年6月19日0—24时,新增境外输入性无症状感染者3例。

无症状感染者1为中国籍,在尼日尔工作,自尼日尔出发,经法国转机,于2022年6月3日抵达上海浦东国际机场,入关后即被集中隔离观察,其间例行核酸检测异常。经排查,区疾控中心新冠病毒核酸检测结果为阳性。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为无症状感染者。

无症状感染者2为中国籍,在法国工作,自法国出发,于2022年6月10日抵达上海浦东国际机场,入关后即被集中隔离观察,其间例行核酸检测异常。经排查,区疾控中心新冠病毒核酸检测结果为阳性。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为无症状感染者。

无症状感染者3为中国籍,在英国留学,自英国出发,经奥地利转机,于2022年6月11日抵达上海浦东国际机场,入关后即被集中隔离观察,其间例行核酸检测异常。经排查,区疾控中心新冠病毒核酸检测结果为阳性。综合流行病学史、临床症状、实验室检测和影像学检查结果等,诊断为无症状感染者。

3例境外输入性无症状感染者已转至定点医疗机构医学观察,同航班密切接触者此前均已落实集中隔离观察。

2022年6月19日0—24时,解除医学观察无症状感染者45例,其中本土无症状感染者43例,境外输入性无症状感染者2例。

2022年2月26日0时至2022年6月19日24时,累计本土确诊58114例,治愈出院57431例,在院治疗95例(其中重型3例,危重型4例),死亡588例。现有待排查的疑似病例0例。

截至2022年6月19日24时,累计境外输入性确诊病例4671例,出院4637例,在院治疗34例。现有待排查的疑似病例0例。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1736463, encodeId=ac671e364639d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Mar 23 20:30:05 CST 2023, time=2023-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353356, encodeId=3e13135335681, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485289, encodeId=c1d5148528957, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617096, encodeId=75bb161e096c2, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227515, encodeId=2ff4122e51503, content=快清零了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:42 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227514, encodeId=71dd122e514cc, content=太好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:36 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2023-03-23 贵阳
  2. [GetPortalCommentsPageByObjectIdResponse(id=1736463, encodeId=ac671e364639d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Mar 23 20:30:05 CST 2023, time=2023-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353356, encodeId=3e13135335681, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485289, encodeId=c1d5148528957, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617096, encodeId=75bb161e096c2, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227515, encodeId=2ff4122e51503, content=快清零了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:42 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227514, encodeId=71dd122e514cc, content=太好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:36 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1736463, encodeId=ac671e364639d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Mar 23 20:30:05 CST 2023, time=2023-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353356, encodeId=3e13135335681, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485289, encodeId=c1d5148528957, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617096, encodeId=75bb161e096c2, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227515, encodeId=2ff4122e51503, content=快清零了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:42 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227514, encodeId=71dd122e514cc, content=太好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:36 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1736463, encodeId=ac671e364639d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Mar 23 20:30:05 CST 2023, time=2023-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353356, encodeId=3e13135335681, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485289, encodeId=c1d5148528957, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617096, encodeId=75bb161e096c2, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227515, encodeId=2ff4122e51503, content=快清零了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:42 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227514, encodeId=71dd122e514cc, content=太好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:36 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1736463, encodeId=ac671e364639d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Mar 23 20:30:05 CST 2023, time=2023-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353356, encodeId=3e13135335681, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485289, encodeId=c1d5148528957, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617096, encodeId=75bb161e096c2, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227515, encodeId=2ff4122e51503, content=快清零了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:42 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227514, encodeId=71dd122e514cc, content=太好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:36 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-06-20 14848244m24(暂无昵称)

    快清零了

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1736463, encodeId=ac671e364639d, content=<a href='/topic/show?id=a421604e721' target=_blank style='color:#2F92EE;'>#最新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=60477, encryptionId=a421604e721, topicName=最新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4bd534165494, createdName=贵阳, createdTime=Thu Mar 23 20:30:05 CST 2023, time=2023-03-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1353356, encodeId=3e13135335681, content=<a href='/topic/show?id=454a59049db' target=_blank style='color:#2F92EE;'>#无症状感染者#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59049, encryptionId=454a59049db, topicName=无症状感染者)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485289, encodeId=c1d5148528957, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1617096, encodeId=75bb161e096c2, content=<a href='/topic/show?id=e660e3936c0' target=_blank style='color:#2F92EE;'>#社会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73936, encryptionId=e660e3936c0, topicName=社会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e6de19781024, createdName=ms705947299214030, createdTime=Tue Jun 21 23:30:05 CST 2022, time=2022-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227515, encodeId=2ff4122e51503, content=快清零了, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:42 CST 2022, time=2022-06-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1227514, encodeId=71dd122e514cc, content=太好了, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f48b5282815, createdName=14848244m24(暂无昵称), createdTime=Mon Jun 20 11:18:36 CST 2022, time=2022-06-20, status=1, ipAttribution=)]
    2022-06-20 14848244m24(暂无昵称)

    太好了

    0

相关资讯

上海新增本土新冠肺炎确诊病例8+8例(2022.6.3)

2022年6月2日0—24时,新增本土新冠肺炎确诊病例8例和无症状感染者8例,其中2例确诊病例为既往无症状感染者转归,3例确诊病例和4例无症状感染者在隔离管控中发现。新增境外输入性新冠肺炎

上海昨日新增本土3+14:上海疫情最新消息(2022.6.14)

均为本市闭环隔离管控人员,其间新冠病毒核酸检测结果异常。

上海昨日新增本土病例“5+9”例(2022.6.4)

2022年6月3日0—24时,新增本土新冠肺炎确诊病例5例和无症状感染者9例,其中2例确诊病例为既往无症状感染者转归,1例确诊病例和8例无症状感染者在隔离管控中发现。新增境外输入性新冠肺炎

上海昨日新增本土“7+9”:上海疫情最新消息(2022.6.11)

在风险人群筛查中发现新冠病毒核酸检测结果异常,即被隔离管控。

上海昨日新增本土11+26例(2022.6.13)

为本市闭环隔离管控人员,其间新冠病毒核酸检测结果异常,经疾控中心复核结果为阳性。

上海昨日新增本土9+7:上海疫情最新消息(2022.6.16)

其中7例确诊病例和7例无症状感染者在隔离管控中发现。